# Hydration Based on Thoitaine, Aloe Vera and Calendula, in the Prevention of Hand-Foot Syndrome in Patients Using Capecitabine

> **NCT04833998** · PHASE2 · UNKNOWN · sponsor: **Instituto Brasileiro de Controle do Cancer** · enrollment: 54 (estimated)

## Conditions studied

- Hand-foot Syndrome

## Interventions

- **DRUG:** Extremecare
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04833998
- **Lead sponsor:** Instituto Brasileiro de Controle do Cancer
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-02
- **Primary completion:** 2021-11-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2021-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04833998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04833998, "Hydration Based on Thoitaine, Aloe Vera and Calendula, in the Prevention of Hand-Foot Syndrome in Patients Using Capecitabine". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04833998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*